Douglas Schottenstein, M.D., opened his own private practice so that he could deliver the highest quality of care in an advanced, self-contained center. He is one of only 200 physicians in the nation who is double board certified in neurology and interventional pain management.
Dr. Schottenstein and his expert staff at NY Spine Medicine treat patients suffering from a variety of acute and chronic painful conditions. Dr. Schottenstein performs a variety of diagnostic and therapeutic procedures and surgeries, including epidurals, transforaminal nerve blocks, sympathetic blocks, facet and sacroiliac joint injections, radiofrequency lesioning, provocative discography, annuloplasty, nucleoplasty, spinal cord stimulation, and intrathecal pumps.
Dr. Schottenstein received his interventional pain management training at Columbia University/ New York Presbyterian Hospital, rated one of the top five hospitals in the nation. He received his neurology training at Emory University, the highest ranked department in the South, and one of the leading programs in the nation.
In addition to leading NY Spine Medicine, Dr. Schottenstein is an attending physician at New York Presbyterian affiliated hospitals, the top-rated hospital system in the region.
Dr. Schottenstein is a highly active member of the American Academy of Neurology, the American Society of Anesthesiology, the American Society of Regional Anesthesia, the International Spine Intervention Society, and the American Society of Interventional Pain Physicians.
Edward Capla, Managing Business Director of the Regenokine Program at NY Spine Medicine, is a graduate of New York University and the Poznan University of Medical Sciences. His mastery and knowledge in the world of orthopaedics has been well recognized through his past work at NYU-Hospital for Joint Diseases, as well as through numerous scientific articles published in various leading orthopaedic journals. He is a recipient of the Smith and Nephew Orthopaedic Journal's "Best Research Article of The Year" award, based on healing bone fractures.
Edward Capla has been instrumental in launching the Regenokine Program on the east coast of the United States. The Regenokine Program is a conservative and non-surgical, customized treatment of any type of inflammation in joints including arthritic toes and fingers, ankles, knees, hips, shoulders, elbows, wrists, carpal tunnel, TMJ, low back, mid back, and neck. This treatment utilizes an advanced biological approach on a molecular cell level to treat the pain, inflammation, and deterioration caused by osteoarthritis.
Edward Capla's expertise fits in perfectly with the patient-centered approach that is a hallmark of the NY Spine Medicine experience - an approach based on scientific evidence and the latest technology designed to fit the individual needs of each patient.
Edward Capla's research and expertise in scientific research along with Dr. Schottenstein's medical expertise and patient care is a winning formula.
More about Regenokine® Program
More about Regenokine® Florida Program
18 E 48th Street Suite 901 New York, New York 10017 T. (212) 750-1155 